CLIVE GOMILLA: Open Payments
NPI 1568047249 · HUMBLE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,686 in 65 payments from 16 companies in 2025. Trend: 2023 $2,377 · 2024 $2,711 · 2025 $1,686
Food & beverage: $1,686
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. | 7 | $344 |
| Novartis Pharmaceuticals Corporation | 11 | $215 |
| Merck Sharp & Dohme LLC | 10 | $207 |
| AstraZeneca Pharmaceuticals LP | 5 | $192 |
| Boston Scientific Corporation | 7 | $191 |
| Novo Nordisk Inc | 9 | $180 |
| Inspire Medical Systems, Inc. | 4 | $91 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $52 |
| E.R. Squibb & Sons, L.L.C. | 2 | $39 |
| GE HEALTHCARE | 1 | $33 |
Products named: Attruby, LEQVIO, WAINUA, VERQUVO, WATCHMAN FLX, Wegovy, INSPIRE, JARDIANCE.
Industry payments across TX — which companies pay providers there.
